Addressing medication shortages
As a leader in pharmaceutical supply chain operations, sourcing, and distribution, Cencora's operations are designed to distribute available supply of regulatory-approved drugs to pharmacies, hospitals, and healthcare providers as quickly, efficiently, and securely as possible. We are committed to the safety, resiliency, and efficiency of the supply chain to help ensure sites of care have timely and reliable access to the critical medications they need to treat their patients.
Medication shortages, which are caused by a variety of factors, present a complex and multifaceted challenge that requires innovative thinking, collaboration among all members of the pharmaceutical supply chain, and targeted solutions to address the root causes and mitigate vulnerabilities.
As an important stakeholder in the pharmaceutical supply chain, we are committed to advancing solutions to create stability for our nation's pharmaceutical products. We will continue to work together with stakeholders across the industry to strengthen the supply chain and address drug shortages. Learn more about the solutions we've introduced and those that we are recommending to address this issue:
Medication shortages, which are caused by a variety of factors, present a complex and multifaceted challenge that requires innovative thinking, collaboration among all members of the pharmaceutical supply chain, and targeted solutions to address the root causes and mitigate vulnerabilities.
As an important stakeholder in the pharmaceutical supply chain, we are committed to advancing solutions to create stability for our nation's pharmaceutical products. We will continue to work together with stakeholders across the industry to strengthen the supply chain and address drug shortages. Learn more about the solutions we've introduced and those that we are recommending to address this issue:
*Cencora includes AmerisourceBergen, a leader in pharmaceutical distribution and supply chain operations in the U.S.
Whitepaper
Addressing generic drug shortages: Contributing factors and public policy recommendations
To address the underlying drivers of generic drug shortages, policymakers must take a comprehensive, multi-pronged approach centered on three goals: enabling sustainable and reliable generic drug manufacturing, increasing stability of supply, and improving the resilience of the domestic supply chain.
Download the whitepaper for a complete outline of our recommendations to combat generic drug shortages or view the executive summary by clicking here.
Download the whitepaper for a complete outline of our recommendations to combat generic drug shortages or view the executive summary by clicking here.
Thought leadership
Keeping pharmacy shelves filled: Solutions to address drug shortages
Heather Zenk, President of U.S. Supply Chain at Cencora, continues to lead the conversation on addressing drug shortages. During her insightful contributions at The Hill's recent event sponsored by the HDA, Heather shared strategies focused on building a more resilient pharmaceutical supply chain and proposed solutions to mitigate the potential impact when shortages do occur.
Watch the video recording to gain valuable perspectives from industry experts on preventing and managing drug shortages for the benefit of patients.
Photo credit: Kristopher Tripplaar Photography
Watch the video recording to gain valuable perspectives from industry experts on preventing and managing drug shortages for the benefit of patients.
Photo credit: Kristopher Tripplaar Photography
We are united in our responsibility to create healthier futures
Through our businesses, we are well-positioned to understand the complexity of the pharmaceutical supply chain, the drivers and impacts of disruptions to the supply chain, and the solutions — including policy – needed to prevent shortages.